| 摘要 |
<p>The invention discloses compositions, combination therapies and methods of treating B cell lymphomas and leukemias, as well as other CD40plus; malignancies. The primary active agent of the composition is an anti CD40L antibody or other CD40L antagonist that inhibits CD40 CD40L interaction. Compositions may additionally contain or utilize any one or more of the following in combination for the treatment of said disease: anti CD20 antibodies, chemotherapeutic agents, chemotherapy cocktails, and radiotherapy.</p> |
